CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 55 filers reported holding CATALYST BIOSCIENCES INC in Q1 2018. The put-call ratio across all filers is 2.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $58,000 | -21.6% | 16,710 | -4.0% | 0.02% | -46.7% |
Q2 2021 | $74,000 | -10.8% | 17,410 | -2.2% | 0.03% | +15.4% |
Q1 2021 | $83,000 | -25.9% | 17,810 | 0.0% | 0.03% | -45.8% |
Q4 2020 | $112,000 | +41.8% | 17,810 | 0.0% | 0.05% | +37.1% |
Q3 2020 | $79,000 | -26.2% | 17,810 | -2.7% | 0.04% | -22.2% |
Q2 2020 | $107,000 | +24.4% | 18,310 | -5.2% | 0.04% | +18.4% |
Q1 2020 | $86,000 | -28.9% | 19,310 | +5.5% | 0.04% | -13.6% |
Q4 2019 | $121,000 | +34.4% | 18,310 | 0.0% | 0.04% | +22.2% |
Q3 2019 | $90,000 | -29.1% | 18,310 | +5.8% | 0.04% | -37.9% |
Q2 2019 | $127,000 | -2.3% | 17,310 | +7.3% | 0.06% | -31.0% |
Q1 2019 | $130,000 | -11.6% | 16,131 | -11.9% | 0.08% | +16.7% |
Q4 2018 | $147,000 | -18.3% | 18,310 | +5.8% | 0.07% | -25.8% |
Q3 2018 | $180,000 | -26.2% | 17,310 | +103.6% | 0.10% | -12.6% |
Q2 2018 | $244,000 | +9.9% | 8,500 | -29.8% | 0.11% | +6.7% |
Q4 2017 | $222,000 | – | 12,100 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 547,541 | $3,214,000 | 6.22% |
ACUTA CAPITAL PARTNERS, LLC | 1,497,900 | $8,793,000 | 2.54% |
22NW, LP | 735,841 | $4,319,000 | 2.34% |
Prosight Management, LP | 248,050 | $1,456,000 | 0.62% |
Worth Venture Partners, LLC | 127,983 | $751,000 | 0.37% |
Parkman Healthcare Partners LLC | 215,237 | $1,263,000 | 0.36% |
Sio Capital Management, LLC | 198,714 | $1,166,000 | 0.34% |
Amtrust Financial Services, Inc. | 50,000 | $294,000 | 0.32% |
Nantahala Capital Management | 1,821,749 | $10,694,000 | 0.32% |
Essex Woodlands Management, Inc. | 78,622 | $462,000 | 0.23% |